215 related articles for article (PubMed ID: 17683499)
1. Transforming growth factor-alpha accelerates hepatocyte repopulation after hepatocyte transplantation.
Kosone T; Takagi H; Horiguchi N; Kakizaki S; Sato K; Watanabe Y; Mori M
J Gastroenterol Hepatol; 2008 Feb; 23(2):260-6. PubMed ID: 17683499
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha.
Vail ME; Pierce RH; Fausto N
Cancer Res; 2001 Jan; 61(2):594-601. PubMed ID: 11212255
[TBL] [Abstract][Full Text] [Related]
3. Autonomous growth in serum-free medium and production of hepatocellular carcinomas by differentiated hepatocyte lines that overexpress transforming growth factor alpha 1.
Wu JC; Merlino G; Cveklova K; Mosinger B; Fausto N
Cancer Res; 1994 Nov; 54(22):5964-73. PubMed ID: 7525051
[TBL] [Abstract][Full Text] [Related]
4. Selective repopulation of mice liver after Fas-resistant hepatocyte transplantation.
Fujino M; Li XK; Kitazawa Y; Funeshima N; Guo L; Okuyama T; Amano T; Amemiya H; Suzuki S
Cell Transplant; 2001; 10(4-5):353-61. PubMed ID: 11549054
[TBL] [Abstract][Full Text] [Related]
5. Rat hepatocyte engraftment in severe combined immunodeficient x beige mice using mouse-specific anti-fas antibody.
Wilson JH; Paturzo FX; Johnson LK; Carreiro MP; Hixson DC; Mennone A; Boyer JL; Pober JS; Harding MJ
Xenotransplantation; 2006 Jan; 13(1):53-62. PubMed ID: 16497212
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor protects against Fas-mediated liver apoptosis in transgenic mice.
Suzuki H; Toyoda M; Horiguchi N; Kakizaki S; Ohyama T; Takizawa D; Ichikawa T; Sato K; Takagi H; Mori M
Liver Int; 2009 Nov; 29(10):1562-8. PubMed ID: 19725891
[TBL] [Abstract][Full Text] [Related]
7. Reduced growth capacity of hepatocytes from c-myc and c-myc/TGF-alpha transgenic mice in primary culture.
Kao CY; Factor VM; Thorgeirsson SS
Biochem Biophys Res Commun; 1996 May; 222(1):64-70. PubMed ID: 8630075
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor reduces Fas-mediated acute liver injury in mice.
Tanaka Y; Sohda T; Matsuo K; Anan A; Irie M; Takeyama Y; Iwata K; Shakado S; Sakisaka S
J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e207-11. PubMed ID: 17784864
[TBL] [Abstract][Full Text] [Related]
9. Synergy between transforming growth factor alpha and hepatitis B virus surface antigen in hepatocellular proliferation and carcinogenesis.
Jakubczak JL; Chisari FV; Merlino G
Cancer Res; 1997 Aug; 57(16):3606-11. PubMed ID: 9270035
[TBL] [Abstract][Full Text] [Related]
10. Selective repopulation of normal mouse liver by Fas/CD95-resistant hepatocytes.
Mignon A; Guidotti JE; Mitchell C; Fabre M; Wernet A; De La Coste A; Soubrane O; Gilgenkrantz H; Kahn A
Nat Med; 1998 Oct; 4(10):1185-8. PubMed ID: 9771754
[TBL] [Abstract][Full Text] [Related]
11. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
Jiang L; Li JG; Lan L; Wang YM; Mao Q; You JP
Transplant Proc; 2010 Nov; 42(9):3773-8. PubMed ID: 21094855
[TBL] [Abstract][Full Text] [Related]
12. Coexpression of C-myc and transforming growth factor alfa in the liver promotes early replicative senescence and diminishes regenerative capacity after partial hepatectomy in transgenic mice.
Factor VM; Jensen MR; Thorgeirsson SS
Hepatology; 1997 Dec; 26(6):1434-43. PubMed ID: 9397983
[TBL] [Abstract][Full Text] [Related]
13. Characterization of double transgenic mice expressing hepatocye growth factor and transforming growth factor alpha.
Shiota G; Kawasaki H; Nakamura T; Schmidt EV
Res Commun Mol Pathol Pharmacol; 1995 Oct; 90(1):17-24. PubMed ID: 8581343
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha.
Okamoto H; Kimura M; Watanabe N; Ogihara M
Eur J Pharmacol; 2009 Feb; 604(1-3):12-9. PubMed ID: 19100731
[TBL] [Abstract][Full Text] [Related]
15. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism for mitogenic signaling via pro-transforming growth factor alpha within hepatocyte nuclei.
Grasl-Kraupp B; Schausberger E; Hufnagl K; Gerner C; Löw-Baselli A; Rossmanith W; Parzefall W; Schulte-Hermann R
Hepatology; 2002 Jun; 35(6):1372-80. PubMed ID: 12029622
[TBL] [Abstract][Full Text] [Related]
17. Liver repopulation by Bcl-x(L) transgenic hepatocytes.
Mitchell C; Mallet VO; Guidotti JE; Goulenok C; Kahn A; Gilgenkrantz H
Am J Pathol; 2002 Jan; 160(1):31-5. PubMed ID: 11786395
[TBL] [Abstract][Full Text] [Related]
18. Constitutive expression of cyclo-oxygenase 2 transgene in hepatocytes protects against liver injury.
Mayoral R; Mollá B; Flores JM; Boscá L; Casado M; Martín-Sanz P
Biochem J; 2008 Dec; 416(3):337-46. PubMed ID: 18671671
[TBL] [Abstract][Full Text] [Related]
19. Tissue transglutaminase (TG2) acting as G protein protects hepatocytes against Fas-mediated cell death in mice.
Sarang Z; Molnár P; Németh T; Gomba S; Kardon T; Melino G; Cotecchia S; Fésüs L; Szondy Z
Hepatology; 2005 Sep; 42(3):578-87. PubMed ID: 16108039
[TBL] [Abstract][Full Text] [Related]
20. Development of liver tumors in transforming growth factor alpha transgenic mice.
Lee GH; Merlino G; Fausto N
Cancer Res; 1992 Oct; 52(19):5162-70. PubMed ID: 1327502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
